Mahmoudi M, Azadmanesh K, Shokrgozar MA, Journeay WS, Laurent S (May 2011). "Effect of nanoparticles on the cell life cycle". Chemical Reviews. 111 (5): 3407–3432. doi:10.1021/cr1003166. PMID21401073.
Bilgin B, Sendur MA, Şener Dede D, Akıncı MB, Yalçın B (September 2017). "A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer". Current Medical Research and Opinion. 33 (9): 1559–1569. doi:10.1080/03007995.2017.1348344. PMID28657360. S2CID205542255.
Schmidt M, Sebastian M (August 2018). "Palbociclib—The First of a New Class of Cell Cycle Inhibitors". Small Molecules in Oncology. Recent Results in Cancer Research. Vol. 211. pp. 153–175. doi:10.1007/978-3-319-91442-8_11. ISBN978-3-319-91441-1. PMID30069766.
Nasmyth K (September 1995). "Evolution of the cell cycle". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 349 (1329): 271–281. doi:10.1098/rstb.1995.0113. PMID8577838.
Morgan DO (November 1997). "Cyclin-dependent kinases: engines, clocks, and microprocessors". Annual Review of Cell and Developmental Biology. 13 (1): 261–291. doi:10.1146/annurev.cellbio.13.1.261. PMID9442875.
Satyanarayana A, Kaldis P (August 2009). "Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms". Oncogene. 28 (33): 2925–2939. doi:10.1038/onc.2009.170. PMID19561645. S2CID3096776.
Ortega S, Prieto I, Odajima J, Martín A, Dubus P, Sotillo R, et al. (September 2003). "Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice". Nature Genetics. 35 (1): 25–31. doi:10.1038/ng1232. PMID12923533. S2CID19522248.
Aleem E, Kiyokawa H, Kaldis P (August 2005). "Cdc2-cyclin E complexes regulate the G1/S phase transition". Nature Cell Biology. 7 (8): 831–836. doi:10.1038/ncb1284. PMID16007079. S2CID10842071.
Harashima H, Dissmeyer N, Schnittger A (July 2013). "Cell cycle control across the eukaryotic kingdom". Trends in Cell Biology. 23 (7): 345–356. doi:10.1016/j.tcb.2013.03.002. PMID23566594.
Ferrell JE (April 2002). "Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability". Current Opinion in Cell Biology. 14 (2): 140–148. doi:10.1016/S0955-0674(02)00314-9. PMID11891111.
Mahmoudi M, Azadmanesh K, Shokrgozar MA, Journeay WS, Laurent S (May 2011). "Effect of nanoparticles on the cell life cycle". Chemical Reviews. 111 (5): 3407–3432. doi:10.1021/cr1003166. PMID21401073.
Bilgin B, Sendur MA, Şener Dede D, Akıncı MB, Yalçın B (September 2017). "A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer". Current Medical Research and Opinion. 33 (9): 1559–1569. doi:10.1080/03007995.2017.1348344. PMID28657360. S2CID205542255.
Schmidt M, Sebastian M (August 2018). "Palbociclib—The First of a New Class of Cell Cycle Inhibitors". Small Molecules in Oncology. Recent Results in Cancer Research. Vol. 211. pp. 153–175. doi:10.1007/978-3-319-91442-8_11. ISBN978-3-319-91441-1. PMID30069766.
Baserga R (June 1965). "The Relationship of the Cell Cycle to Tumor Growth and Control of Cell Division: A Review". Cancer Research. 25 (5): 581–595. PMID14347544.
Nasmyth K (September 1995). "Evolution of the cell cycle". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 349 (1329): 271–281. doi:10.1098/rstb.1995.0113. PMID8577838.
Morgan DO (November 1997). "Cyclin-dependent kinases: engines, clocks, and microprocessors". Annual Review of Cell and Developmental Biology. 13 (1): 261–291. doi:10.1146/annurev.cellbio.13.1.261. PMID9442875.
Satyanarayana A, Kaldis P (August 2009). "Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms". Oncogene. 28 (33): 2925–2939. doi:10.1038/onc.2009.170. PMID19561645. S2CID3096776.
Ortega S, Prieto I, Odajima J, Martín A, Dubus P, Sotillo R, et al. (September 2003). "Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice". Nature Genetics. 35 (1): 25–31. doi:10.1038/ng1232. PMID12923533. S2CID19522248.
Aleem E, Kiyokawa H, Kaldis P (August 2005). "Cdc2-cyclin E complexes regulate the G1/S phase transition". Nature Cell Biology. 7 (8): 831–836. doi:10.1038/ncb1284. PMID16007079. S2CID10842071.
Harashima H, Dissmeyer N, Schnittger A (July 2013). "Cell cycle control across the eukaryotic kingdom". Trends in Cell Biology. 23 (7): 345–356. doi:10.1016/j.tcb.2013.03.002. PMID23566594.
Ferrell JE (April 2002). "Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability". Current Opinion in Cell Biology. 14 (2): 140–148. doi:10.1016/S0955-0674(02)00314-9. PMID11891111.
Bilgin B, Sendur MA, Şener Dede D, Akıncı MB, Yalçın B (September 2017). "A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer". Current Medical Research and Opinion. 33 (9): 1559–1569. doi:10.1080/03007995.2017.1348344. PMID28657360. S2CID205542255.
Satyanarayana A, Kaldis P (August 2009). "Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms". Oncogene. 28 (33): 2925–2939. doi:10.1038/onc.2009.170. PMID19561645. S2CID3096776.
Ortega S, Prieto I, Odajima J, Martín A, Dubus P, Sotillo R, et al. (September 2003). "Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice". Nature Genetics. 35 (1): 25–31. doi:10.1038/ng1232. PMID12923533. S2CID19522248.
Aleem E, Kiyokawa H, Kaldis P (August 2005). "Cdc2-cyclin E complexes regulate the G1/S phase transition". Nature Cell Biology. 7 (8): 831–836. doi:10.1038/ncb1284. PMID16007079. S2CID10842071.